Angion Biomedica Corp (ANGN) Stock
ANGN is no longer traded. Angion Biomedica was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 1, 2023 at $1.00.
Angion Biomedica stock price history
ANGN final trading statistics
- Final close
- $1.00
- Final trading day
- Jun 1, 2023
- Market cap at delisting
- $30.11M
- Shares outstanding
- 30.11M
- Final 52-week range
- $0.46 – $2.04
- Avg. volume (final 3 mo.)
- 91,772
- All-time high (split-adj.)
- $257.40 · Feb 2021
- All-time low (split-adj.)
- $4.80 · Mar 2023
- Return since IPO
- -94.1%
- Beta
- 0.60
- Book value / share
- $1.32
- Price / book
- 0.76
Angion Biomedica annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $2.30M | -$55.7M | -$1.29 |
| FY2021 | $28.31M | -$67.2M | -$2.09 |
| FY2020 | $2.88M | -$104.3M | -$57.65 |
| FY2019 | $1.49M | -$44.7M | — |
| FY2018 | $4.03M | -$20.0M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Angion Biomedica Corp
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York.
Angion Biomedica stock FAQ
What happened to Angion Biomedica stock?
Angion Biomedica stock was delisted from the Nasdaq. Its final close was $1.00 on June 1, 2023.
Is ANGN stock still trading?
No. ANGN was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of ANGN stock?
ANGN closed at $1.00 on its final trading day, June 1, 2023, for a market value of about $30.11M.
What were Angion Biomedica's revenue and earnings in its last full fiscal year?
Angion Biomedica reported revenue of $2.30M and net income of -$55.7M in fiscal 2022, its last full year as a public company.
When did Angion Biomedica go public?
Angion Biomedica Corp stock began trading on February 5, 2021.